My watch list
my.chemeurope.com  
Login  

Armodafinil



Armodafinil
Systematic (IUPAC) name
(-)-2-[(R)-(diphenylmethyl)sulfinyl]acetamide
Identifiers
CAS number 68693-11-8
ATC code N06BA07
PubChem 9690109
Chemical data
Formula C15H15NO2S 
Mol. mass 273.351
Pharmacokinetic data
Bioavailability  ?
Metabolism Hepatic, including CYP3A4 and other pathways
Half life 12-15 hrs
Excretion Urine (as metabolites)
Therapeutic considerations
Pregnancy cat.

C

Legal status

Schedule IV (USA)

Routes Oral

Armodafinil (Nuvigil®) is an eugeroic drug produced by the pharmaceutical company Cephalon Inc., which was approved by the FDA on June 15, 2007.

Additional recommended knowledge

Cephalon plans to conduct clinical trials evaluating the use of Nuvigil as a treatment for serious medical conditions such as bipolar depression, cognition associated with schizophrenia, and excessive sleepiness and fatigue in conditions such as Parkinson's disease and cancer.

Nuvigil is protected by a U.S. patent expiring in 2023 that claims the Form 1 polymorph of armodafinil.

See also

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Armodafinil". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE